Clinical trial
An Observational Study Evaluating the Safety of Topiramate for the Prevention of…
NCT00297336 · Janssen Cilag Pharmaceutica S.A.C.I., Greece, Industry · Completed
Key facts
| NCT number | NCT00297336 |
|---|---|
| Title | An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine |
| Official title | An Open-label Observational Safety Study During Administration of Topiramate, for the Prophylaxis of Migraine |
| Lead sponsor | Janssen Cilag Pharmaceutica S.A.C.I., Greece, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Migraine Disorders |
| Intervention type | Drug |
| Interventions | Topiramate |
| Enrollment | 80 |
| Start date | Mar 1, 2005 |
| Completion | Feb 1, 2007 |
| First posted | Feb 28, 2006 |
| Last update posted | Apr 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: